These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 14678390)
1. Pharmacological characteristics of Ro 115-1240, a selective alpha1A/1L-adrenoceptor partial agonist: a potential therapy for stress urinary incontinence. Blue DR; Daniels DV; Gever JR; Jett MF; O'Yang C; Tang HM; Williams TJ; Ford AP BJU Int; 2004 Jan; 93(1):162-70. PubMed ID: 14678390 [TBL] [Abstract][Full Text] [Related]
2. A randomized crossover study to evaluate Ro 115-1240, a selective alpha1A/1L-adrenoceptor partial agonist in women with stress urinary incontinence. Musselman DM; Ford AP; Gennevois DJ; Harbison ML; Laurent AL; Mokatrin AS; Stoltz RR; Blue DR BJU Int; 2004 Jan; 93(1):78-83. PubMed ID: 14678373 [TBL] [Abstract][Full Text] [Related]
3. In vitro alpha1-adrenoceptor pharmacology of Ro 70-0004 and RS-100329, novel alpha1A-adrenoceptor selective antagonists. Williams TJ; Blue DR; Daniels DV; Davis B; Elworthy T; Gever JR; Kava MS; Morgans D; Padilla F; Tassa S; Vimont RL; Chapple CR; Chess-Williams R; Eglen RM; Clarke DE; Ford AP Br J Pharmacol; 1999 May; 127(1):252-8. PubMed ID: 10369480 [TBL] [Abstract][Full Text] [Related]
4. A randomized crossover study to evaluate RO 115-1240, a selective alpha1A/1L-adrenoceptor partial agonist in women with stress urinary incontinence. Wein AJ BJU Int; 2004 Jun; 93(9):1361. PubMed ID: 15180647 [No Abstract] [Full Text] [Related]
5. Pharmacological properties of A-204176, a novel and selective alpha1A adrenergic agonist, in in vitro and in vivo models of urethral function. O'Neill AB; Buckner SA; Brune ME; Milicic I; Daza AV; Gauvin DM; Altenbach RJ; Meyer MD; Williams M; Sullivan JP; Brioni JD Life Sci; 2001 Nov; 70(2):181-97. PubMed ID: 11787943 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological properties of 2-((R-5-chloro-4-methoxymethylindan-1-yl)-1H-imidazole (PF-3774076), a novel and selective alpha1A-adrenergic partial agonist, in in vitro and in vivo models of urethral function. Conlon K; Christy C; Westbrook S; Whitlock G; Roberts L; Stobie A; McMurray G J Pharmacol Exp Ther; 2009 Sep; 330(3):892-901. PubMed ID: 19498105 [TBL] [Abstract][Full Text] [Related]
7. Pharmacological characterization of alpha-adrenoceptors that mediate contraction in splenic artery strips from the pig. Barbieri A; Santagostino-Barbone MG; Zonta F; Lucchelli A Naunyn Schmiedebergs Arch Pharmacol; 1998 Jun; 357(6):654-61. PubMed ID: 9686942 [TBL] [Abstract][Full Text] [Related]
8. Agonist pharmacology at recombinant α1A - and α1L -adrenoceptors and in lower urinary tract α1 -adrenoceptors. Yoshiki H; Uwada J; Umada H; Kobayashi T; Takahashi T; Yamakawa T; Yamaguchi A; Yokoyama O; Muramatsu I Br J Pharmacol; 2013 Nov; 170(6):1242-52. PubMed ID: 24024968 [TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo uroselectivity of B8805-033, an antagonist with high affinity at prostatic alpha1A- vs. alpha1B- and alpha1D-adrenoceptors. Eltze M; Boer R; Michel MC; Hein P; Testa R; Ulrich WR; Kolassa N; Sanders KH Naunyn Schmiedebergs Arch Pharmacol; 2001 Jun; 363(6):649-62. PubMed ID: 11414660 [TBL] [Abstract][Full Text] [Related]
11. A randomized crossover study to evaluate Ro 115-1240, a selective alpha-adrenoceptor partial agonist in women with stress urinary incontinence. Wein AJ BJU Int; 2004 May; 93(7):1115. PubMed ID: 15142177 [No Abstract] [Full Text] [Related]
12. Pharmacological analysis of the novel, selective alpha1-adrenoceptor antagonist, KMD-3213, and its suitability as a tritiated radioligand. Murata S; Taniguchi T; Muramatsu I Br J Pharmacol; 1999 May; 127(1):19-26. PubMed ID: 10369451 [TBL] [Abstract][Full Text] [Related]
14. Analysis of alpha 1L-adrenoceptor pharmacology in rat small mesenteric artery. Stam WB; Van der Graaf PH; Saxena PR Br J Pharmacol; 1999 Jun; 127(3):661-70. PubMed ID: 10401556 [TBL] [Abstract][Full Text] [Related]
15. Comparative effects of calcium channel blockers and indomethacin on insulin secretion and blood pressure increase derived from alpha 1-adrenoceptor stimulation in the rabbit. García-Barrado MJ; Reverte M; Palomero J; Moratinos J J Auton Pharmacol; 1997 Oct; 17(5):293-302. PubMed ID: 9427108 [TBL] [Abstract][Full Text] [Related]
16. Selectivity of oxymetazoline for urethral pressure vs blood pressure in the anaesthetized female rabbit. Modiri AR; Fredrickson MG; Gillberg PG; Alberts P Scand J Urol Nephrol; 2000 Jun; 34(3):151-6. PubMed ID: 10961466 [TBL] [Abstract][Full Text] [Related]
17. Functional and radioligand binding characterization of the α1L-adrenoceptor subtype of the human vas deferens. Davis BJ; Wiener M; Chapple CR; Sellers DJ; Chess-Williams R Auton Autacoid Pharmacol; 2015 Apr; 34(3-4):41-9. PubMed ID: 25790239 [TBL] [Abstract][Full Text] [Related]
18. ABT-866, a novel alpha(1A)-adrenoceptor agonist with antagonist properties at the alpha(1B)- and alpha(1D)-adrenoceptor subtypes. Buckner SA; Milicic I; Daza AV; Meyer MD; Altenbach RJ; Williams M; Sullivan JP; Brioni JD Eur J Pharmacol; 2002 Aug; 449(1-2):159-65. PubMed ID: 12163120 [TBL] [Abstract][Full Text] [Related]
19. Modification of alpha1 -adrenoceptors by peroxynitrite as a possible mechanism of systemic hypotension in sepsis. Takakura K; Taniguchi T; Muramatsu I; Takeuchi K; Fukuda S Crit Care Med; 2002 Apr; 30(4):894-9. PubMed ID: 11940765 [TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of buflomedil on prostate alpha1A adrenoceptor in the Wistar rat. Tang LM; Cheng JT; Tong YC Neurosci Lett; 2004 Sep; 367(2):224-7. PubMed ID: 15331158 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]